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Abstract
The WHO recently declared that the novel influenza H1N1 virus was responsible for the 2009 flu pandemic. As the virus continues to
spread globally and affect more individuals, more complications of infection with this virus are being recognized. To our knowledge, we
report the first case of H1N1-induced rhabdomyolysis leading to acute renal failure in an adult. This case highlights the importance of
recognizing a significant extrapulmonary complication of H1N1 infection.
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The WHO recently declared that the novel influenza H1N1
virus was responsible for the 2009 flu pandemic. As the virus
continues to spread globally and affects more individuals,
more complications of infection with this new virus are being
recognized. Pulmonary complications of super-imposed bac-
terial pneumonia, respiratory failure and acute respiratory
distress syndrome have been reported [1]. While these pul-
monary complications have been frequently documented
because of their associated morbidity and mortality, other
complications have not been as widely recognized. One of
these complications is H1N1 influenza-associated rhabdomy-
olysis. A recent case series report noted mild to moderate
elevations in creatinine kinase levels in 62% patients with
2009 H1N1 pneumonia and respiratory failure [1]. Although
virus-induced myopathy is a well-recognized phenomenon
dating back to the early 1900s, only two cases of H1N1-
associated rhabdomyolysis have been reported in the litera-
ture [2,3]. To our knowledge, we present the first case of
H1N1-induced rhabdomyolysis leading to acute renal failure
in an adult. This case report also discusses the pathogenesis
and virulence factors associated with influenza-associated
myopathy.
Case report
A 59-year-old male presented in October 2009 for routine
laboratory work and was found with elevated serum creati-
nine and liver function test values. He was subsequently
admitted to general medicine for further workup. His
medical history included hypertension, diabetes mellitus and
dyslipidaemia. Home medications included metoprolol
100 mg twice daily, lisinopril 40 mg once daily, glyburide
10 mg twice daily, metformin 1000 mg twice daily and
simvastatin 20 mg once daily. One week prior to admission,
he experienced generalized weakness and myalgia associated
with subjective fevers, chills, rhinorrhoea and a nonproduc-
tive cough. In addition, he experienced one day of four
large-volume, watery bowel movements. He subsequently
developed maroon-coloured urine and decreased urine
output. He had no associated nausea or vomiting. There was
no history of trauma. He denied alcohol or drug abuse. On
examination, vital signs were normal, respiratory examination
was normal and the rest of his examination was unremark-
able. Laboratory values at admission were notable for serum
creatinine (6.0 mg/dL), blood urea nitrogen (63 mg/dL),
aspartate aminotransferase (693 IU/L), alanine aminotransfer-
ase (150 IU/L) and creatinine kinase (>41 000 U/L). Our
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laboratory does not report creatinine kinase levels >41 000.
Urinalysis showed positive dipstich for blood with four red
blood cells per high-power field on microscopic examination.
Myoglobin was not assayed. Respiratory samples (nasopha-
ryngeal and pharyngeal swabs) were sent on admission for
H1N1 virus detection and returned positive. H1N1 virus
was detected by real-time RT-PCR following the CDC
protocol at the City Health Laboratory.
Simvastatin, lisinopril and oral hypoglycemics were imme-
diately discontinued on admission. Also, the patient was
found to be oliguric. Mild hydration with normal saline was
started at a rate of 40–60 mL/h. Intravenous furosemide was
used on an as-needed basis to attempt forced diuresis. How-
ever, he did not respond to forced diuresis and serum creat-
inine increased by 2 mg/dL daily. Serum creatinine peaked at
14.6 mg/dL and blood urea nitrogen peaked at 136 mg/dL.
Haemodialysis was initiated. The patient received a total of
five sessions of haemodialysis for metabolic abnormalities
before electrolytes stabilized and urine output increased.
Serum creatinine, creatinine kinase and liver enzyme levels
showed a downward trend. After a two-week hospital stay,
the patient was discharged home. One week post-discharge
a laboratory check revealed a serum creatinine of 3.5 mg/dL.
Discussion
To our knowledge, acute renal failure due to rhabdomyolysis
from the H1N1 infection has not been previously reported.
Although a recent case series analysis showed mild to mod-
erate elevations in creatinine kinase levels in 62% of patients
with 2009 H1N1 pneumonia and respiratory failure [1], our
patient did not manifest severe pulmonary complications
from the virus. Two cases of rhabdomyolysis with H1N1
infection have been reported in the literature [2,3]. These
cases were without associated renal failure (see Table 1).
The first report was that of a 16-year-old boy with a CK
level of 164 149 U/L [2]. The first adult case described was
that of a 28-year-old woman with rhabdomyolysis and
H1N1-induced respiratory failure [3]. Benign acute childhood
myositis secondary to H1N1 infection has also been
described in the literature [4].
The differential diagnosis of nontraumatic, nonexertional
rhabdomyolysis is wide. In our patient, the differential diag-
nosis included virus-induced rhabdomyolysis and statin-
induced rhabdomyolysis. Although statin-induced rhabdomy-
olysis could not be excluded, it was thought to be less likely.
The patient had been on low dose simvastatin for many
years with normal liver function tests and no previous com-
plaint of myalgia. In large clinical trials, severe rhabdomyolysis
with acute renal failure has not been seen in patients without
other risk factors. Unfortunately, a muscle biopsy ruling out
an underlying metabolic myopathy or polymyositis to identify
a risk factor for rhabdomyolysis was not obtained. More-
over, a muscle biopsy showing direct viral invasion may have
offered a definitive diagnosis.
The clinical picture sugested a diagnosis of virus-induced
rhabdomyolysis. In fact, influenza constitutes the majority of
virus-induced rhabdomyolysis.
Tanaka et al. [5] reviewed viral causes of rhabdomyolysis
and found that 44% (14 of 42) of cases were caused by influ-
enza virus. Another review, by Singh and Scheld [6],
reported that 42% (25 of 59) of cases were associated with
influenza virus A or B. Other reported viral aetiologies
include HIV, coxsackie, Epstein-Barr, echovirus, cytomegalo-
virus, adenovirus, herpes simplex, parainfluenza, and vari-
cella-zoster.
Influenza-associated myopathy is a well-known phenome-
non. In 1896, Leichtenstren [7] first described the associa-
tion as ‘muscular neuralgias’ affecting the back, thighs, and
calves of patients.
In 1970, Middleton et al. [8] provided further evidence of
this phenomenon by correlating epidemiological and clinical
data with laboratory evidence of influenza infection and mus-
cle breakdown. They found elevated CK levels in 14 patients
with confirmed influenza. Muscle biopsies were not obtained
in these patients.
The exact pathogenesis of influenza-induced myopathy
remains ill defined. Muscle biopsy appears to be non-specific.
Pathological signs range from non-specific degenerative
changes and muscle cell vacuolization to patchy or extensive
muscle necrosis.
However, muscle biopsies have provided insight into the
pathogenesis of this clinical entity. Proposed mechanisms
include direct viral invasion and immune-mediated mecha-
nisms. Armstrong et al. [9] showed that human skeletal mus-
cle cells in tissue culture were susceptible to influenza virus.
Clinical evidence of direct viral invasion is limited. Gamboa
et al. [10] confirmed the direct invasion hypothesis by cultur-
ing the virus from human muscle. They described influenza B
virus isolation, and immunofluorescence and electronmicros-
copy data in skeletal muscle in a 65-year-old man with
TABLE 1. Case reports of H1N1-induced rhabdomyolysis





Our case 59 Male >41 000 6.0
D’Silva et al. [2] 16 Male 164 149 Normal
Ayala et al. [3] 28 Female 27 820 0.9
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myoglobinuria. Light microscopy revealed numerous necrotic
muscle fibres in large foci, surrounded by normal appearing
muscle. Influenza B virus was identified by neutralization and
haemagglutination inhibition tests using influenza B/Lee anti-
serum. Viral presence was confirmed by specific immunofluo-
rescence and by orthomyxovirus-like particles on
electronmicroscopy [10].
Despite these reports, viral isolation proves to be difficult
and is rarely reported. Other authors have proposed an
immune-mediated process because of the failure to isolate
the virus. However, this may be secondary to sampling error
or the timing of biopsy. Davis and Kornfeld [11] provided an
alternate theory.
Using an experimental murine model, they supported the
hypothesis that a non-permissive viral infection can develop
in skeletal muscle. This process can damage specific nuclear
domains of muscle fibres producing muscle degeneration or
necrosis, leading to a focal or patchy process [11]. It is well
known that influenza viruses bind to glycoproteins and gan-
gliosides according to in vitro assays, but data on virulence
factors particular to muscle cell cultures are largely lacking.
Servidei et al. [12] suggested a unique role of NB protein for
influenza B, surmising myotropic properties. The NB protein
is an integral membrane protein of the influenza B virion and
may play a role in virus entry [13]. Still, the effects of virus-
related proteins and viral nucleic acid in skeletal muscle are
poorly understood. Further experimental studies are needed
to identify the virulence factors and underlying molecular
mechanisms responsible for influenza-induced myopathy.
Severe rhabdomyolysis can be complicated by acute renal
failure. Interestingly, influenza-induced rhabdomyolysis has a
greater propensity to cause renal failure than the other viral
aetiologies. The previously mentioned reports by Tanaka
et al. [5] and Singh and Scheld [6] provide evidence of this
association with 57% (8 of 14) and 44% (11 of 25) of influ-
enza cases, respectively, developing acute renal failure. More
experimental evidence is needed to elucidate the exact path-
ogenesis of influenza-induced rhabdomyolysis and the
increased associated incidence of renal failure in comparison
to rhabdomyolysis of other viral aetiologies.
In the face of the worldwide H1N1 pandemic, physicians
must recognize both the pulmonary and extrapulmonary
complications of this novel infection. Our case demonstrates
the importance of recognizing severe rhabdomyolysis as a
complication of H1N1 infection and its potential association
with life-threatening acute renal failure and electrolyte
imbalances.
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